The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable excitement within the sector. A shift away from Schedule I status, often regarded as outdated and hindering advancement, could unlock significant opportunities for ventures. Reduced regulatory restrictions, alongside greater access to get more … Read More